Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

HIV and HCV Intervention In Drug Treatment Settings - 1

This study has been completed.
Sponsor:
Collaborator:
Oregon Health and Science University
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00102349
First received: January 27, 2005
Last updated: April 13, 2010
Last verified: April 2010

January 27, 2005
April 13, 2010
November 2004
February 2006   (final data collection date for primary outcome measure)
HIV/HCV injection risk behaviors
Not Provided
Complete list of historical versions of study NCT00102349 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
HIV and HCV Intervention In Drug Treatment Settings - 1
HIV and HCV Intervention in Drug Treatment Settings

The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.

Not Provided
Interventional
Phase 3
Primary Purpose: Prevention
Behavior Therapy
Behavioral: Behavior Therapy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
706
February 2006
February 2006   (final data collection date for primary outcome measure)

Volunteers will be IV drug users already enrolled in drug detoxification treatment.

Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00102349
NIDA-CTN-0017-1
Yes
Robert Booth, Ph.D., University of Colorado at Denver
University of Colorado, Denver
Oregon Health and Science University
Principal Investigator: Robert Booth, Ph.D. University of Colorado, Denver
National Institute on Drug Abuse (NIDA)
April 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP